PURPOSE: To develop a consistent and reproducible method in an animal model for studies of radiofrequency (RF) ablation of primary hepatocellular carcinoma (HCC). MATERIALS AND METHODS: Fifteen woodchucks were inoculated with woodchuck hepatitis virus (WHV) to establish chronic infections. When serum γ-glutamyl transpeptidase levels became elevated, the animals were evaluated with ultrasound, and, in most cases, preoperative magnetic resonance (MR) imaging to confirm tumor development. Ultimately, RF ablation of tumors was performed by using a 1-cm probe with the animal submerged in a water bath for grounding. Ablation effectiveness was evaluated with contrast-enhanced MR imaging and gross and histopathologic analysis. RESULTS: RF ablation was performed in 15 woodchucks. Modifications were made to the initial study design to adapt methodology for the woodchuck. The last 10 of these animals were treated with a standardized protocol using a 1-cm probe that produced a consistent area of tumor necrosis (mean size of ablation, 10.2 mm × 13.1 mm) and led to no complications. CONCLUSIONS: A safe, reliable and consistent method was developed to study RF ablation of spontaneous primary HCC using chronically WHV-infected woodchucks, an animal model of hepatitis B virus-induced HCC.
PURPOSE: To develop a consistent and reproducible method in an animal model for studies of radiofrequency (RF) ablation of primary hepatocellular carcinoma (HCC). MATERIALS AND METHODS: Fifteen woodchucks were inoculated with woodchuck hepatitis virus (WHV) to establish chronic infections. When serum γ-glutamyl transpeptidase levels became elevated, the animals were evaluated with ultrasound, and, in most cases, preoperative magnetic resonance (MR) imaging to confirm tumor development. Ultimately, RF ablation of tumors was performed by using a 1-cm probe with the animal submerged in a water bath for grounding. Ablation effectiveness was evaluated with contrast-enhanced MR imaging and gross and histopathologic analysis. RESULTS:RF ablation was performed in 15 woodchucks. Modifications were made to the initial study design to adapt methodology for the woodchuck. The last 10 of these animals were treated with a standardized protocol using a 1-cm probe that produced a consistent area of tumor necrosis (mean size of ablation, 10.2 mm × 13.1 mm) and led to no complications. CONCLUSIONS: A safe, reliable and consistent method was developed to study RF ablation of spontaneous primary HCC using chronically WHV-infected woodchucks, an animal model of hepatitis B virus-induced HCC.
Authors: Fred T Lee; Dieter Haemmerich; Andrew S Wright; David M Mahvi; Lisa A Sampson; John G Webster Journal: J Vasc Interv Radiol Date: 2003-11 Impact factor: 3.464
Authors: C Gouillat; D Manganas; F Zoulim; D Vitrey; G Saguier; M Guillaud; J F Ain; R Duque-Campos; C Jamard; M Praves; C Trepo Journal: J Hepatol Date: 1997-06 Impact factor: 25.083
Authors: Bud C Tennant; Ilia A Toshkov; Simon F Peek; James R Jacob; Stephan Menne; William E Hornbuckle; Raymond D Schinazi; Brent E Korba; Paul J Cote; John L Gerin Journal: Gastroenterology Date: 2004-11 Impact factor: 22.682
Authors: F Marchal; D Elias; P Rauch; A Leroux; J Stinès; J L Verhaeghe; F Guillemin; J P Villemot Journal: Eur Surg Res Date: 2004 Mar-Apr Impact factor: 1.745
Authors: James R Jacob; Agnes Sterczer; Ilia A Toshkov; Amy E Yeager; Brent E Korba; Paul J Cote; Marie-Annick Buendia; John L Gerin; Bud C Tennant Journal: Hepatology Date: 2004-04 Impact factor: 17.425
Authors: William F Pritchard; David L Woods; Juan A Esparza-Trujillo; Matthew F Starost; Michal Mauda-Havakuk; Andrew S Mikhail; Ivane Bakhutashvili; Shelby Leonard; Elizabeth C Jones; Venkatesh Krishnasamy; John W Karanian; Bradford J Wood Journal: J Vasc Interv Radiol Date: 2020-02-24 Impact factor: 3.464
Authors: Terence P F Gade; Stephen J Hunt; Neil Harrison; Gregory J Nadolski; Charles Weber; Stephen Pickup; Emma E Furth; Mitchell D Schnall; Michael C Soulen; M Celeste Simon Journal: J Vasc Interv Radiol Date: 2015-04-08 Impact factor: 3.464
Authors: Michal Mauda-Havakuk; Michael T Kassin; Andrew S Mikhail; Juan A Esparza-Trujillo; Ivane Bakhutashvili; David L Woods; Paul G Wakim; Matthew F Starost; John W Karanian; Bradford J Wood; William F Pritchard Journal: J Vasc Interv Radiol Date: 2021-11-17 Impact factor: 3.464
Authors: Scott M Thompson; Matthew R Callstrom; Bruce Knudsen; Jill L Anderson; Kim A Butters; Joseph P Grande; Lewis R Roberts; David A Woodrum Journal: Cardiovasc Intervent Radiol Date: 2012-08-25 Impact factor: 2.740
Authors: Quirina M B de Ruiter; Sheng Xu; Ming Li; William F Pritchard; Matthew F Starost; Armando Filie; Andrew S Mikhail; Michal Mauda-Havakuk; Juan A Esparza-Trujillo; Ivane Bakhutashvili; Pedram Heidari; Umar Mahmood; John W Karanian; Bradford J Wood Journal: Cardiovasc Intervent Radiol Date: 2021-05-21 Impact factor: 2.797
Authors: Kyle M Schachtschneider; Regina M Schwind; Jordan Newson; Nickolas Kinachtchouk; Mark Rizko; Nasya Mendoza-Elias; Paul Grippo; Daniel R Principe; Alex Park; Nana H Overgaard; Gregers Jungersen; Kelly D Garcia; Ajay V Maker; Laurie A Rund; Howard Ozer; Ron C Gaba; Lawrence B Schook Journal: Front Oncol Date: 2017-08-23 Impact factor: 6.244
Authors: Michal Mauda-Havakuk; Andrew S Mikhail; Matthew F Starost; Elizabeth C Jones; Baktiar Karim; David E Kleiner; Ari Partanen; Juan A Esparza-Trujillo; Ivane Bakhutashvili; Paul G Wakim; Michael T Kassin; Andrew L Lewis; John W Karanian; Bradford J Wood; William F Pritchard Journal: J Hepatocell Carcinoma Date: 2021-03-09
Authors: Xiaoqiang Qi; Guangfu Li; Dai Liu; Anjan Motamarry; Xiangwei Huang; A Marissa Wolfe; Kristi L Helke; Dieter Haemmerich; Kevin F Staveley-O'Carroll; Eric T Kimchi Journal: Cancer Biol Ther Date: 2015 Impact factor: 4.875